N
Nirmal Kumar Jain
Researcher at Manipal Hospitals
Publications - 81
Citations - 1997
Nirmal Kumar Jain is an academic researcher from Manipal Hospitals. The author has contributed to research in topics: Tuberculosis & Drug carrier. The author has an hindex of 23, co-authored 80 publications receiving 1792 citations. Previous affiliations of Nirmal Kumar Jain include Post Graduate Institute of Medical Education and Research.
Papers
More filters
Journal Article
Niosomes As Drug Carriers
Alok Namdeo,Nirmal Kumar Jain +1 more
TL;DR: Alternatives to phospholipids are of interest from the technical viewpoint and could also allow a wider study of the influence of chemical composition on the biological fate of vesicles3.
Journal ArticleDOI
Interstitial Lung Disease in India. Results of a Prospective Registry
Sheetu Singh,Bridget F. Collins,Bharat Bhushan Sharma,Jyotsna M Joshi,Deepak Talwar,Sandeep Katiyar,Nishtha Singh,Lawrence A. Ho,Jai Kumar Samaria,Parthasarathi Bhattacharya,Rakesh K. Gupta,Sudhir Chaudhari,Tejraj Singh,Vijay Moond,Sudhakar Pipavath,Jitesh Ahuja,Ravindran Chetambath,Aloke Gopal Ghoshal,Nirmal Kumar Jain,H. J. Gayathri Devi,Surya Kant,Parvaiz A Koul,Raja Dhar,Rajesh Swarnakar,Surendra K. Sharma,Dhrubajyoti Roy,Kripesh R. Sarmah,Bhavin Jankharia,Rodney A. Schmidt,Santosh K. Katiyar,Arpita Jindal,Mangal Dk,Virendra Singh,Ganesh Raghu +33 more
TL;DR: Hypersensitivity pneumonitis was the most common new‐onset ILD in India, followed by CTD‐ILD and idiopathic pulmonary fibrosis; diagnoses varied between site investigators and CILD experts, emphasizing the value of MDD in ILD diagnosis.
Journal ArticleDOI
Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl-4H-quinazolin-3-yl)-urea
TL;DR: It can be concluded that newly synthesized compounds possessed promising CNS activities after screening for anticonvulsant, CNS depressant and sedative-hypnotic activity in mice.
Journal Article
Ethosomes : A Novel Vesicular Carrier For Enhanced Transdermal Delivery Of An AntiHIV Agent
TL;DR: It can be concluded from the study that complex lipid molecule, ethosomes can increase the transdermal flux, prolong the release and present an attractive route for the sustained delivery of zidovudine.
Journal ArticleDOI
A new approach in gastroretentive drug delivery system using cholestyramine.
TL;DR: CAB-coated microcapsules could be a floating as well as a mucoadhesive drug delivery system endowed with floating ability due to the carbon dioxide generation when exposed to the gastric fluid and has promise in the treatment of Helicobacter pylori.